文献速递关节外科

术前使用曲马多对初次全髋与全膝关节置换术后阿片类药物处方的影响:11,000例患者的单机构经验

The Effect of Preoperative Tramadol Use on Postoperative Opioid Prescriptions After Primary Total Hip and Knee Arthroplasty: An Institutional Experience of 11,000 Patients.
PubMed 文献 · J Arthroplasty · 2022-03-01

回顾性分析11,667例初次单侧全髋和全膝关节置换术患者,按术前用药分为未用过阿片类、曲马多、麻醉药、麻醉药联合曲马多四组。术前曲马多使用与术后阿片类药物使用增加相关,全髋患者术后需续方风险为未用药者的2.5倍。作者结论不推荐在术前使用曲马多镇痛。

要点

  • 术前使用曲马多者术后阿片类药物续方率和总用量均高于未用过阿片类者。
  • 全髋患者术前用曲马多者术后续方风险为未用药者的2.5倍。
  • 作者不推荐在TKA或THA术前使用曲马多镇痛。

核心结论

  • 作者结论:不推荐在TKA或THA术前使用曲马多镇痛,外科医生和患者应知悉其与术后阿片类药物使用大幅增加相关。

研究设计与样本

  • 单机构回顾性研究,纳入11,667例初次单侧全髋和全膝关节置换术患者。
  • 术前分组:未用过阿片类8,201例(70.3%)、曲马多1,315例(11.3%)、麻醉药1,408例(12.1%)、麻醉药联合曲马多743例(6.3%)。
  • 比较住院期间、出院时处方及术后90天内续方的吗啡毫克当量(MME),并用多因素分析评估术前曲马多使用与续方次数及总续方MME的关系。

主要发现

  • 住院期间总MME在四组分别为119、152、211和196 MME(P < .001),未用过阿片类组最低,其余三组显著增高。
  • 住院期间每日MME在四组分别为66、74、100和86 MME(P < .001)。
  • 阿片类药物续方率在四组分别为32%、42%、41%和52%(P < .001),未用过阿片类组显著更低。
  • 出院后处方总MME在四组分别为477、528、590和658(P < .001),未用过阿片类组最低。
  • 控制年龄、性别、焦虑/抑郁史后,全髋患者术前用曲马多者术后需续方的可能性为未用过阿片类者的2.5倍,且续方MME多80 MME(P < .001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative opioid use increases opioid consumption postoperatively, but the effect of tramadol is poorly understood. METHODS: We retrospectively reviewed 11,667 patients undergoing primary unilateral THA and TKA at a single institution. Preoperatively, there were 8,201 opioid-naïve patients (70.3%), 1,315 on tramadol (11.3%), 1,408 on narcotics (12.1%) and 743 on narcotics and tramadol (6.3%). We compared morphine milligram equivalents (MMEs) used during hospitalization, prescribed at discharge, and refilled during the first 90 days. We used multivariate analysis to assess whether preoperative tramadol use was associated with increased number of refills and total refilled MMEs. RESULTS: Total in-hospital MMEs and daily MMEs was lowest for the opioid naïve patients and significantly increased for the remaining three groups (total in-hospital use: 119, 152, 211, and 196 MMEs, respectively-P < .001) (daily in-hospital use: 66, 74, 100, and 86 MMEs, respectively-P < .001). Opioid refill rate was significantly higher for all patients who were not opioid naïve (32%, 42%, 41%, and 52%, respectively-P < .001). Total MMEs prescribed after discharge was lowest for opioid naïve patients (477, 528, 590 and 658, respectively-P < .001). Logistic and linear regression controlling for age, sex, history of anxiety/depression revealed that THA patients taking tramadol preoperatively were 2.5 times more likely to require post-discharge refills and refilled 80 additional MMEs than opioid naïve patients (P < .001). CONCLUSION: Tramadol is not recommended for pain beforeTKA or THA, and surgeons and patients should be aware that it is associated with a substantial increase in postoperative opioid use.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Chalmers BP, LeBrun DG, Lebowitz J, et al. The Effect of Preoperative Tramadol Use on Postoperative Opioid Prescriptions After Primary Total Hip and Knee Arthroplasty: An Institutional Experience of 11,000 Patients. J Arthroplasty. 2022. PMID: 35240282. doi:10.1016/j.arth.2022.02.093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。